Microfluidics‑based optimization of neuroleukin‑mediated regulation of articular chondrocyte proliferation

Tian,Kang; Zhong,Weiliang; Zhang,Yingqiu; Yin,Baosheng; Zhang,Weiguo; Liu,Han

doi:10.3892/mmr.2015.4540

Microfluidics‑based optimization of neuroleukin‑mediated regulation of articular chondrocyte proliferation

Authors:
- Kang Tian
- Weiliang Zhong
- Yingqiu Zhang
- Baosheng Yin
- Weiguo Zhang
- Han Liu
View Affiliations

Affiliations: Department of Orthopaedics, First Affiliated Hospital, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, Liaoning 116044, P.R. China
Published online on: November 10, 2015 https://doi.org/10.3892/mmr.2015.4540
Pages: 67-74
Copyright: © Tian et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Due to the low proliferative and migratory capacities of chondrocytes, cartilage repair remains a challenging clinical problem. Current therapeutic strategies for cartilage repair result in unsatisfactory outcomes. Autologous chondrocyte implantation (ACI) is a cell based therapy that relies on the in vitro expansion of healthy chondrocytes from the patient, during which proliferation‑promoting factors are frequently used. Neuroleukin (NLK) is a multifunctional protein that possesses growth factor functions, and its expression has been associated with cartilage development and bone regeneration, however its direct role in chondrocyte proliferation remains to be fully elucidated. In the current study, the role of NLK in chondrocyte proliferation in vitro in addition to its potential to act as an exogenous factor during ACI was investigated. Furthermore, the concentration of NLK for in vitro chondrocyte culture was optimized using a microfluidic device. An NLK concentration of 12.85 ng/ml was observed to provide optimal conditions for the promotion of chondrocyte proliferation. Additionally, NLK stimulation resulted in an increase in type II collagen synthesis by chondrocytes, which is a cartilaginous secretion marker and associated with the phenotype of chondrocytes. Together these data suggest that NLK is able to promote cell proliferation and type II collagen synthesis during in vitro chondrocyte propagation, and thus may serve as an exogenous factor for ACI.

View Figures

View References

1	Wang Q, Huang C, Xue M and Zhang X: Expression of endogenous BMP-2 in periosteal progenitor cells is essential for bone healing. Bone. 48:524–532. 2011. View Article : Google Scholar :
2	Wilusz RE, Sanchez-Adams J and Guilak F: The structure and function of the pericellular matrix of articular cartilage. Matrix Biol. 39:25–32. 2014. View Article : Google Scholar : PubMed/NCBI
3	Demoor M, Ollitrault D, Gomez-Leduc T, Bouyoucef M, Hervieu M, Fabre H, Lafont J, Denoix JM, Audigié F, Mallein-Gerin F, et al: Cartilage tissue engineering: Molecular control of chondrocyte differentiation for proper cartilage matrix reconstruction. Biochim Biophys Acta. 1840:2414–2440. 2014. View Article : Google Scholar : PubMed/NCBI
4	Jiang Y and Tuan RS: Origin and function of cartilage stem/progenitor cells in osteoarthritis. Nat Rev Rheumatol. 11:206–212. 2015. View Article : Google Scholar
5	Rodrigues MT, Gomes ME and Reis RL: Current strategies for osteochondral regeneration: From stem cells to pre-clinical approaches. Curr Opin Biotechnol. 22:726–733. 2011. View Article : Google Scholar : PubMed/NCBI
6	Kock L, van Donkelaar CC and Ito K: Tissue engineering of functional articular cartilage: The current status. Cell Tissue Res. 347:613–627. 2012. View Article : Google Scholar :
7	van Osch GJ, Brittberg M, Dennis JE, Bastiaansen-Jenniskens YM, Erben RG, Konttinen YT and Luyten FP: Cartilage repair: Past and future–lessons for regenerative medicine. J Cell Mol Med. 13:792–810. 2009. View Article : Google Scholar : PubMed/NCBI
8	Edwards PK, Ackland T and Ebert JR: Clinical rehabilitation guidelines for matrix-induced autologous chondrocyte implantation on the tibiofemoral joint. J Orthop Sports Phys Ther. 44:102–119. 2014. View Article : Google Scholar
9	Yu SM and Kim SJ: The thymoquinone-induced production of reactive oxygen species promotes dedifferentiation through the ERK pathway and inflammation through the p38 and PI3K pathways in rabbit articular chondrocytes. Int J Mol Med. 35:325–332. 2015.
10	Goessler UR, Hörmann K and Riedel F: Tissue engineering with chondrocytes and function of the extracellular matrix (Review). Int J Mol Med. 13:505–513. 2004.PubMed/NCBI
11	Foldager CB: Advances in autologous chondrocyte implantation and related techniques for cartilage repair. Dan Med J. 60:B46002013.PubMed/NCBI
12	Yanagawa T, Funasaka T, Tsutsumi S, Watanabe H and Raz A: Novel roles of the autocrine motility factor/phosphoglucose isomerase in tumor malignancy. Endocr Relat Cancer. 11:749–759. 2004. View Article : Google Scholar : PubMed/NCBI
13	Funasaka T and Raz A: The role of autocrine motility factor in tumor and tumor microenvironment. Cancer Metastasis Rev. 26:725–735. 2007. View Article : Google Scholar : PubMed/NCBI
14	Tsutsumi S, Hogan V, Nabi IR and Raz A: Overexpression of the autocrine motility factor/phosphoglucose isomerase induces transformation and survival of NIH-3T3 fibroblasts. Cancer Res. 63:242–249. 2003.PubMed/NCBI
15	Shih WL, Liao MH, Lin PY, Chang CI, Cheng HL, Yu FL and Lee JW: PI 3-kinase/Akt and STAT3 are required for the prevention of TGF-beta-induced Hep3B cell apoptosis by autocrine motility factor/phosphoglucose isomerase. Cancer Lett. 290:223–237. 2010. View Article : Google Scholar
16	Kho DH, Nangia-Makker P, Balan V, Hogan V, Tait L, Wang Y and Raz A: Autocrine motility factor promotes HER2 cleavage and signaling in breast cancer cells. Cancer Res. 73:1411–1419. 2013. View Article : Google Scholar :
17	Tsutsumi S, Yanagawa T, Shimura T, Fukumori T, Hogan V, Kuwano H and Raz A: Regulation of cell proliferation by autocrine motility factor/phosphoglucose isomerase signaling. J Biol Chem. 278:32165–32172. 2003. View Article : Google Scholar : PubMed/NCBI
18	Silletti S and Raz A: Autocrine motility factor is a growth factor. Biochem Biophys Res Commun. 194:446–457. 1993. View Article : Google Scholar : PubMed/NCBI
19	Zhi J, Sommerfeldt DW, Rubin CT and Hadjiargyrou M: Differential expression of neuroleukin in osseous tissues and its involvement in mineralization during osteoblast differentiation. J Bone Miner Res. 16:1994–2004. 2001. View Article : Google Scholar : PubMed/NCBI
20	Li Y, Qin J, Lin B and Zhang W: The effects of insulin-like growth factor-1 and basic fibroblast growth factor on the proliferation of chondrocytes embedded in the collagen gel using an integrated microfluidic device. Tissue Eng Part C Methods. 16:1267–1275. 2010. View Article : Google Scholar : PubMed/NCBI
21	Spahn G, Kahl E, Muckley T, Hofmann GO and Klinger HM: Arthroscopic knee chondroplasty using a bipolar radiofrequency-based device compared to mechanical shaver: Results of a prospective, randomized, controlled study. Knee Surg Sports Traumatol Arthrosc. 16:565–573. 2008. View Article : Google Scholar : PubMed/NCBI
22	Gelse K, von der Mark K, Aigner T, Park J and Schneider H: Articular cartilage repair by gene therapy using growth factor-producing mesenchymal cells. Arthritis Rheum. 48:430–441. 2003. View Article : Google Scholar : PubMed/NCBI
23	Haene R, Qamirani E, Story RA, Pinsker E and Daniels TR: Intermediate outcomes of fresh talar osteochondral allografts for treatment of large osteochondral lesions of the talus. J Bone Joint Surg Am. 94:1105–1110. 2012. View Article : Google Scholar : PubMed/NCBI
24	Nukavarapu SP and Dorcemus DL: Osteochondral tissue engineering: Current strategies and challenges. Biotechnol Adv. 31:706–721. 2013. View Article : Google Scholar
25	Chan BP and Leong KW: Scaffolding in tissue engineering: General approaches and tissue-specific considerations. Eur Spine J. 17(Suppl 4): 467–479. 2008. View Article : Google Scholar : PubMed/NCBI
26	Cheng CW, Solorio LD and Alsberg E: Decellularized tissue and cell-derived extracellular matrices as scaffolds for orthopaedic tissue engineering. Biotechnol Adv. 32:462–484. 2014. View Article : Google Scholar : PubMed/NCBI
27	Krejci P, Masri B, Fontaine V, Mekikian PB, Weis M, Prats H and Wilcox WR: Interaction of fibroblast growth factor and C-natriuretic peptide signaling in regulation of chondrocyte proliferation and extracellular matrix homeostasis. J Cell Sci. 118:5089–5100. 2005. View Article : Google Scholar : PubMed/NCBI
28	Phornphutkul C, Wu KY, Yang X, Chen Q and Gruppuso PA: Insulin-like growth factor-I signaling is modified during chon-drocyte differentiation. J Endocrinol. 183:477–486. 2004. View Article : Google Scholar : PubMed/NCBI
29	Bobick BE and Kulyk WM: The MEK-ERK signaling pathway is a negative regulator of cartilage-specific gene expression in embryonic limb mesenchyme. J Biol Chem. 279:4588–4595. 2004. View Article : Google Scholar
30	Gikas PD, Bayliss L, Bentley G and Briggs TW: An overview of autologous chondrocyte implantation. J Bone Joint Surg Br. 91:997–1006. 2009. View Article : Google Scholar : PubMed/NCBI
31	Araki K, Shimura T, Yajima T, Tsutsumi S, Suzuki H, Okada K, Kobayashi T, Raz A and Kuwano H: Phosphoglucose isomerase/autocrine motility factor promotes melanoma cell migration through ERK activation dependent on autocrine production of interleukin-8. J Biol Chem. 284:32305–32311. 2009. View Article : Google Scholar : PubMed/NCBI
32	Niizeki H, Kobayashi M, Horiuchi I, Akakura N, Chen J, Wang J, Hamada JI, Seth P, Katoh H, Watanabe H, et al: Hypoxia enhances the expression of autocrine motility factor and the motility of human pancreatic cancer cells. Br J Cancer. 86:1914–1919. 2002. View Article : Google Scholar : PubMed/NCBI
33	Timar J, Trikha M, Szekeres K, Bazaz R, Tovari J, Silletti S, Raz A and Honn KV: Autocrine motility factor signals integrin-mediated metastatic melanoma cell adhesion and invasion. Cancer Res. 56:1902–1908. 1996.PubMed/NCBI
34	Niinaka Y, Paku S, Haga A, Watanabe H and Raz A: Expression and secretion of neuroleukin/phosphohexose isomerase/maturation factor as autocrine motility factor by tumor cells. Cancer Res. 58:2667–2674. 1998.PubMed/NCBI
35	Dobashi Y, Watanabe H, Matsubara M, Yanagawa T, Raz A, Shimamiya T and Ooi A: Autocrine motility factor/glucose-6-phosphate isomerase is a possible predictor of metastasis in bone and soft tissue tumours. J Pathol. 208:44–53. 2006. View Article : Google Scholar
36	Luo Y, Long JM, Lu C, Chan SL, Spangler EL, Mascarucci P, Raz A, Longo DL, Mattson MP, Ingram DK and Weng NP: A link between maze learning and hippocampal expression of neuroleukin and its receptor gp78. J Neurochem. 80:354–361. 2002. View Article : Google Scholar : PubMed/NCBI
37	Yang Y, Cheng XR, Zhang GR, Zhou WX and Zhang YX: Autocrine motility factor receptor is involved in the process of learning and memory in the central nervous system. Behav Brain Res. 229:412–418. 2012. View Article : Google Scholar : PubMed/NCBI
38	Funasaka T, Haga A, Raz A and Nagase H: Tumor autocrine motility factor is an angiogenic factor that stimulates endothelial cell motility. Biochem Biophys Res Commun. 285:118–128. 2001. View Article : Google Scholar : PubMed/NCBI
39	Bhise NS, Ribas J, Manoharan V, Zhang YS, Polini A, Massa S, Dokmeci MR and Khademhosseini A: Organ-on-a-chip platforms for studying drug delivery systems. J Control Release. 190:82–93. 2014. View Article : Google Scholar : PubMed/NCBI
40	Björnmalm M, Yan Y and Caruso F: Engineering and evaluating drug delivery particles in microfluidic devices. J Control Release. 190:139–149. 2014. View Article : Google Scholar : PubMed/NCBI
41	Ye N, Qin J, Shi W, Liu X and Lin B: Cell-based high content screening using an integrated microfluidic device. Lab Chip. 7:1696–1704. 2007. View Article : Google Scholar : PubMed/NCBI
42	Kane BJ, Zinner MJ, Yarmush ML and Toner M: Liver-specific functional studies in a microfluidic array of primary mammalian hepatocytes. Anal Chem. 78:4291–4298. 2006. View Article : Google Scholar : PubMed/NCBI
43	Tourovskaia A, Figueroa-Masot X and Folch A: Differentiation-on-a-chip: A microfluidic platform for long-term cell culture studies. Lab Chip. 5:14–19. 2005. View Article : Google Scholar
44	Zhong W, Tian K, Zheng X, Li L, Zhang W, Wang S and Qin J: Mesenchymal stem cell and chondrocyte fates in a multishear microdevice are regulated by Yes-associated protein. Stem Cells Dev. 22:2083–2093. 2013. View Article : Google Scholar : PubMed/NCBI
45	Sanz-Ramos P, Duart J, Rodríguez-Goñi MV, Vicente-Pascual M, Dotor J, Mora G and Izal-Azcárate I: Improved Chondrogenic Capacity of Collagen Hydrogel-Expanded Chondrocytes: In Vitro and in Vivo Analyses. J Bone Joint Surg Am. 96:1109–1117. 2014. View Article : Google Scholar : PubMed/NCBI
46	Bobick BE, Chen FH, Le AM and Tuan RS: Regulation of the chondrogenic phenotype in culture. Birth Defects Res C Embryo Today. 87:351–371. 2009. View Article : Google Scholar : PubMed/NCBI